18707-63-6

Usage

Uses

Used in Pharmaceutical Industry:
5-AMINOMETHYL-FURAN-2-CARBOXYLIC ACID ETHYL ESTER is used as a chemical intermediate for the synthesis of various pharmaceuticals. Its unique structure allows it to be a key component in the development of new drug candidates, particularly those with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 5-AMINOMETHYL-FURAN-2-CARBOXYLIC ACID ETHYL ESTER is utilized as an intermediate in the production of agrochemicals. Its role in this industry is crucial for the synthesis of compounds that can be used in pest control and crop protection, contributing to enhanced agricultural productivity.
Used in Research and Development:
5-AMINOMETHYL-FURAN-2-CARBOXYLIC ACID ETHYL ESTER is employed as a research compound for exploring its potential pharmacological properties. Scientists and researchers use this ester to investigate its interactions with biological systems and to develop a deeper understanding of its therapeutic potential, which can lead to the discovery of novel treatments and medications.

InChI:InChI=1/C8H11NO3/c1-2-11-8(10)7-4-3-6(5-9)12-7/h3-4H,2,5,9H2,1H3

Upstream product

• 170499-95-3 ethyl 5-(azidomethyl)furan-2-carboxylate 
• 2528-00-9 5-Chloromethyl-furan-2-carboxylic acid ethyl ester 

Downstream Products

• 1452520-43-2 5-({4-[({[5-(4-methoxyphenyl)-1H-indazol-3-yl]carbonyl}amino)methyl]piperidin-1-yl}methyl)furan-2-carboxylic acid 
• 1452520-45-4 5-({4-[({[5-(2,3-difluorophenyl)-1H-indazol-3-yl]carbonyl}amino)methyl]piperidin-1-yl}methyl)furan-2-carboxylic acid 
• 1452520-47-6 5-({4-[({[5-(2-fluorophenyl)-1H-indazol-3-yl]carbonyl}amino)-methyl]piperidin-1-yl}methyl)furan-2-carboxylic acid 

Relevant academic research and scientific papers

COMPOSITIONS AND METHODS USING THE SAME FOR TREATMENT OF NEURODEGENERATIVE AND MITOCHONDRIAL DISEASE

The present disclosure is directed, in part, to compounds, or pharmaceutically acceptable salts thereof, for the treatment and/or prevention of neurodegenerative disease, mitchonodrial disease, fibrosis, and/or cardiomyopathy.

COMPOSITIONS AND METHODS USING THE SAME FOR TREATMENT OF NEURODEGENERATIVE AND MITOCHONDRIAL DISEASE

The present disclosure is directed, in part, to compounds, or pharmaceutically acceptable salts thereof, for the treatment and/or prevention of neurodegenerative disease and/or mitchonodrial disease including Parkinson's disease and Leigh's disease.

SUBSTITUTED-QUINOXALINE-TYPE-PIPERIDINE COMPOUNDS AND THE USES THEREOF

The invention relates to Substituted-Quinoxaline-Type Piperidine Compounds, compositions comprising an effective amount of a Substituted-Quinoxaline-Type Piperidine Compound and methods to treat or prevent a condition, such as pain, comprising administeri

Benzoxazepinones and their use as squalene synthase inhibitors

There is disclosed a compound represented by the formula [I]: wherein R1 is optionally substituted 1-carboxyethyl group, optionally substituted alkyl-sulfonyl group, optionally substituted (carboxy-cycloalkyl)-alkyl group, -X1-X2-Ar-X3-X4-COOH (wherein X1 and X4 are a bond or alkylene group, X2 and X3 are a bond, -O-, -S-, Ar is divalent aromatic group etc.), R2 is alkyl group optionally substituted with alkanoyloxy group and/or hydroxy group, R3 is alkyl group, and W is halogen atom, etc., or a salt thereof. The compound has the cholesterol lowering activity and the triglyceride lowering activity and is useful for preventing and/or treating hyperlipidemia.